Gastric antisecretory and antiulcer effects of simvastatin in rats
Mohammad Tariq,
Haseeb A Khan,
Ibrahim Elfaki,
Mohammad Arshaduddin,
Meshal Al Moutaery,
Hannan Al Rayes,
Ramiz Al Swailam,
Corresponding Author
Mohammad Tariq
Research Center, Armed Forces Hospital, Riyadh, and
Professor Mohammad Tariq, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Kingdom of Saudi Arabia. Email: [email protected]Search for more papers by this authorHaseeb A Khan
Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for more papers by this authorIbrahim Elfaki
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorMohammad Arshaduddin
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorMeshal Al Moutaery
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorHannan Al Rayes
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorRamiz Al Swailam
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorMohammad Tariq,
Haseeb A Khan,
Ibrahim Elfaki,
Mohammad Arshaduddin,
Meshal Al Moutaery,
Hannan Al Rayes,
Ramiz Al Swailam,
Corresponding Author
Mohammad Tariq
Research Center, Armed Forces Hospital, Riyadh, and
Professor Mohammad Tariq, Armed Forces Hospital, PO Box 7897 (W-912), Riyadh 11159, Kingdom of Saudi Arabia. Email: [email protected]Search for more papers by this authorHaseeb A Khan
Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Search for more papers by this authorIbrahim Elfaki
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorMohammad Arshaduddin
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorMeshal Al Moutaery
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorHannan Al Rayes
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorRamiz Al Swailam
Research Center, Armed Forces Hospital, Riyadh, and
Search for more papers by this authorAbstract
Background and Aim: Recently, statins have appeared to have additional benefits beyond their lipid lowering effects, which has led to the interest in the use of this class of drugs outside the realm of cardiovascular disease. Simvastatin (SIM) is a commonly prescribed statin with anti-inflammatory and antioxidant properties. Excessive generation of oxygen-derived free radicals (ODFR) and proinflammatory mediators has been implicated in the pathogenesis of gastric ulcers. This investigation aimed to study the effect of SIM on experimentally induced gastric acid secretion and ulcer formation.
Methods: Adult Wistar rats were divided into experimental groups containing six animals. Acid secretion studies were undertaken using pylorus-ligated rats pretreated with SIM (20, 40, and 60 mg/kg). The effect of orally administered SIM was also studied on indomethacin- and ethanol-induced gastric ulcers. The levels of myeloperoxidase (MPO), non-protein sulfhydryls (NP-SH), nitric oxide (NO), antioxidant enzymes, and gastric wall mucus were measured in the glandular stomach of rats following ethanol-induced gastric lesions.
Results: Administration of SIM significantly and dose-dependently inhibited the volume of gastric secretion and the acidity. Pretreatment with SIM significantly reduced the formation of indomethacin- and ethanol-induced gastric lesions. The antiulcer activity of SIM was associated with significant attenuation of adverse effects of ethanol on gastric wall mucus, NP-SH and MPO. SIM modified the gastric NO levels and reversed the ethanol-induced decrease in glutathione-S-transferase and increase in superoxide dismutase and catalase.
Conclusions: These findings clearly suggest the involvement of proinflammatory agents and ODFR in the pathogenesis of gastric lesions. The gastroprotective effects of SIM are mediated by inhibition of neutrophils activity, reduction of oxidative stress, and maintenance of vascular integrity. This study was conducted in rats; its relevance to human gastric ulcers is not known and warrants further study.
References
- 1 Holm L. Gastric mucosal blood flow and mucosal protection. J. Clin. Gastroenterol. 1988; 1: S114–19.
- 2 Sato N, Kawano S, Tsuji S, Ogihara T, Yamada S. Gastric blood flow in ulcer diseases. Scand. J. Gastroenterol. Suppl. 1995; 208: 14–20.
- 3 Ma L, Elliot SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc. Natl Acad. Sci. USA 2001; 98: 6470–5.
- 4 Oda M, Han JY, Nakamura M. Endothelial cell dysfunction in microvasculature: relevance to disease processes. Clin. Hemorheol. Microcirc. 2000; 23: 199–211.
- 5 Catalayud S, Barrachina D, Esplugues JV. Nitric oxide: relation to integrity, injury, and healing of the gastric mucosa. Microsc. Res. Tech. 2001; 53: 325–35.
- 6 Whittle BJ, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br. J. Pharmacol. 1990; 99: 607–11.
- 7 Martin MJ, Jimenez MD, Motilva V. New issues about nitric oxide and its effects on the gastrointestinal tract. Curr. Pharm. Des. 2001; 7: 881–908.
- 8 Pan L, Tang Q, Fu Q, Hu B, Xiang J, Qian J. Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer in mice. Acta Pharmacol. Sin. 2005; 26: 1334–8.
- 9 Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a re-evaluation. Am. J. Physiol. 1988; 245: G768–74.
- 10 Otamiri T, Tagesson C. Role of phospholipase A2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am. J. Surg. 1989; 157: 562–5.
- 11 Konturek PC, Dua A, Brzozowski T et al. Activation of genes for superoxide dismutase, interleukin-1β, tumor necrosis factor-α and intercellular adhesion molecule-1 during healing of ischemia-reperfusion gastric injury. Scand. J. Gastroenterol. 2000; 35: 452–63.
- 12 Lynch JR, Wang H, McGirt MJ et al. Simvastatin reduces vasospasm after aneurismal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005; 36: 2024–6.
- 13 Miida T, Takahashi A, Tanabe N, Ikeuchi T. Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression? Curr. Opin. Lipidol. 2005; 16: 619–23.
- 14 Vollmer T, Key L, Durkalski V et al. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 2004; 363: 1607–8.
- 15 Scalia R, Gooszen ME, Jones SP et al. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apoliprotein E-deficient mice. Circulation 2001; 103: 2598–603.
- 16 Pruefer D, Scalia R, Lefer AM. Simvastatin inhibits leukocytes–endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler. Thromb. Vasc. Biol. 1999; 19: 2894–900.
- 17 Franzoni F, Quinones-Galvan A, Regoli F, Ferrannini E, Galetta F. A comparative study of the in vitro antioxidant activity of statins. Int. J. Cardiol. 2003; 90: 317–21.
- 18 Ungureanu D, Filip C, Artenie A, Artenie R. Evaluation of simvastatin antioxidant effects. Rev. Med. Chir. Soc. Med. Nat. Iasi 2003; 107: 66–71.
- 19 Delbosc S, Morena M, Djouad F, Ledoucen C, Descomps B, Cristol JP. Statins, 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J. Cardiovasc. Pharmacol. 2002; 40: 611–17.
- 20 Carneado J, Alvarez de Sotomayor M, Perez-Guerrero C et al. Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect. J. Hypertens. 2002; 20: 429–37.
- 21 Trochu JN, Mital S, Zhang X et al. Preservation of NO production by statins in treatment of heart failure. Cardiovasc. Res. 2003; 60: 250–8.
- 22 Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW, Li YJ. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Acta Pharmacol. Sin. 2004; 25: 893–901.
- 23 Dobrucki LE, Kalinowski L, Dobrucki IT, Malinski T. Statin-stimulated nitric oxide release from endothelium. Med. Sci. Monit. 2001; 7: 622–7.
- 24 Schror K, Lobel P, Steinhagen-Thiessen E. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Eicosanoids 1989; 2: 39–45.
- 25 Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga C, Mulligan MS. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J. Thorac. Cardiovasc. Surg. 2003; 126: 482–9.
- 26 Inman SR, Davis NA, Olson KM, Lukaszek VA. Simvastatin attenuates renal ischemia/reperfusion injury in rats administered cyclosporin A. Am. J. Med. Sci. 2003; 326: 117–21.
- 27 Rendig SV, Symons JD, Amsterdam EA. Effects of statins on myocardial and coronary artery response to ischemia-reperfusion. Can. J. Physiol. Pharmacol. 2003; 81: 1064–71.
- 28 Shabanzadeh AP, Shuaib A, Wang CX. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res. 2005; 1042: 1–5.
- 29 Ito M, Suzuki Y, Ishihara M, Suzuki Y. Anti-ulcer effects of antioxidants: effect of probucol. Eur. J. Pharmacol. 1998; 354: 189–96.
- 30 Valcavi U, Caponi R, Brambilla A et al. Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-norprostanoid acid in experimental animals. Arzneimittelforschung 1982; 32: 657–63.
- 31 Schiantarelli P, Cadel S, Folco GC. Gastroprotective effects of morniflumate, an esterified anti-inflammatory drug. Arzneimittelforschung 1984; 34: 885–90.
- 32 Shay H, Kumarov SA, Fels SA, Meraze D, Gruenstein M, Siplet H. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945; 5: 43–61.
- 33 Bhargava KP, Gupta MB, Tangri KK. Mechanism of ulcerogenic activity of indomethacin and ocyphenbutazone. Eur. J. Pharmacol. 1973; 22: 191–5.
- 34 Natale G, Lazzeri G, Blandizzi C et al. Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol. Appl. Pharmacol. 2001; 174: 17–26.
- 35 Corne SJ, Morrisey SM, Woods RJ. A method for the quantitative estimation of gastric barrier mucus. J. Physiol. (London) 1974; 242: 116–17.
- 36 Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982; 78: 206–9.
- 37 Owen WG. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 1980; 106: 207–12.
- 38 Habig WH, Pabst MJ, Jokoby WB. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974; 249: 7130–9.
- 39 Marklund S, Marklund G. Involvement of superoxide anion radical in the autoxidation of pyragallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974; 47: 469–74.
- 40 Claiborne A. Catalase activity. In: RA Greenwald, ed. CRC Handbook of Methods in Oxygen Radical Research. Boca Raton, FL: CRC Press, 1985; 283–4.
- 41 Navarro-Gonzálvez JA, García-Benayas C, Arenas J. Semiautomated measurement of nitrate in biological fluids. Clin. Chem. 1998; 44: 679–81.
- 42 Dedieu Chaufour C, Hertz F, Caussade F, Cloarec A. Pharmacological profile of UP 5145–52, an original antiulcer and anti-secretory agent. J. Pharmacol. Exp. Ther. 1991; 259: 190–7.
- 43 Dixit C, Rastogi L, Dikshit M. Effect of nitric oxide modulators on pylorus-ligation-induced ulcers in the rat. Pharmacol. Res. 1999; 39: 33–9.
- 44 Wagner KA, Nandi J, King RL, Levine RA. Effect of NSAIDs on ulcerogenesis and gastric secretion in pylorus ligated rats. Dig. Dis. Sci. 1995; 40: 134–40.
- 45 Goa KL, Monk JP. Enprostil: a preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 1987; 3: 539–59.
- 46 Takeuchi K, Sugamoto S, Yamamoto H, Kawauchi S, Tashima K. Interactive roles of endogenous prostaglandins and nitric oxide in regulation of acid secretion by damaged stomachs. Aliment. Pharmacol. Ther. 2000; 1: 125–34.
- 47 Tanaka J, Yuda Y, Inouye S, Yamakawa T. The role of nitric oxide in the gastric acid secretion induced by ischemia-reperfusion in the pylorus-ligated rat. Eur. J. Pharmacol. 2001; 424: 69–74.
- 48 Luo DE, Chen AF. Nitric oxide: a newly discovered function on wound healing. Acta Pharmacol. Sin. 2005; 26: 259–64.
- 49 Anthony A, Sim R, Dhillon AP, Pounder RE, Wakefield AJ. Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut 1996; 39: 363–8.
- 50 Kalia N, Brown NJ, Jacob S, Reed MW, Bardhan KD. Studies on gastric mucosal microcirculation. 1. The nature of regional variations induced by ethanol injury. Gut 1997; 40: 31–5.
- 51 Naito Y, Yoshikawa T, Kaneko T et al. Role of oxygen radicals in indomethacin-induced gastric mucosal microvascular injury in rats. J. Clin. Gastroenterol. 1993; 17: S99–103.
- 52 Takeuchi Y, Kitano S, Bandoh T et al. Acceleration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation? Eur. Surg. Res. 2003; 35: 75–80.
- 53 Patel HM, Santani DD, Goswami SG. Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. Pharmacology 2001; 63: 154–9.
- 54 Nakamura M, Akiba Y, Kishikawa H, Oda M, Ishii H. Effect of combined administration of lansoprazole and sofalcone on microvascular and connective tissue regeneration after ethanol-induced gastric mucosal damage. J. Clin. Gastroenterol. 1998; 27: S170–7.
- 55 Jayaraj AP, Lewin MR, Tovey FI, Kitler ME, Clark CG. The protective effect of meciadanol (o-methyl-3 (+)-catechin) on experimental ulceration. Eur. J. Pharmacol. 1988; 147: 265–71.
- 56 Padol I, Huang JQ, Hunt RH. Anti-ulcerogenic properties of endothelin receptor antagonists in the rat. Aliment Pharmacol. Ther. 1999; 13: 537–44.
- 57 Ma L, Wallace JL. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2000; 279: 341–6.
- 58 Cho CH. Current roles of nitric oxide in gastrointestinal disorders. J. Physiol. Paris 2001; 95: 253–6.
- 59 Di Napoli P, Antonio TA, Grilli A et al. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc. Res. 2001; 51: 283–93.
- 60 Griffin M, Ray W, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann. Intern. Med. 1988; 109: 359–63.
- 61 Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 1990; 300: 278–84.
- 62 Lippman W. Inhibition of indomethacin induced gastric ulceration in the rat by perorally administered synthetic and natural prostaglandin analogues. Prostaglandins 1974; 7: 1–9.
- 63 Kasuya Y, Urushiadani T, Okabe S. Effects of various drugs and vagotomy on indomethacin induced gastric ulcers in the rat. Jpn. J. Pharmacol. 1979; 29: 670–3.
- 64 Wallace JL. Non-steroid anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined. Scand. J. Gastroenterol. Suppl. 1992; 192: 3–8.
- 65 Choi M, Rolle S, Rane M, Haller H, Luft FC, Kettritz R. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int. 2003; 63: 96–106.
- 66 Laine L, Weinstein WM. Histology of alcoholic haemorrhagic gastritis: a prospective evaluation. Gastroenterology 1988; 94: 1254–64.
- 67 Shimizu N, Watanabe T, Arakawa T, Fujiwara Y, Higuchi K, Kuroki T. Pentoxyfyllin accelerates gastric ulcer healing in rats: roles of tumor necrosis factor α and neutrophils during the early phase of ulcer healing. Digestion 2000; 61: 157–64.
- 68 Kvietys PR, Twohigh B, Danzell J, Specian RD. Ethanol-induced injury to the rat gastric mucosa. Gastroenterology 1990; 98: 909–20.
- 69 Elsbach P, Weiss J. Phagocytosis of bacteria and phospholipi degradation. Biochim. Biophys. Acta 1988; 947: 29–52.
- 70 Hernandez LA, Grisham MB, Twohigh B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia reperfusion induced microvasculars injury. Am. J. Physiol. 1987; 253: 699–703.
- 71 Miller TA, Li D, Kuo YJ, Schmidt KL, Shanbour LL. Nonprotein sulfhydryl compounds in canine gastric mucosa: effect of PGE2 and ethanol. Am. J. Physiol. 1985; 249: 137–44.
- 72 La Casa C, Villegas I, Alarcon de la Lastra C, Motilva V, Martin Calero MJ. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol-induced gastric lesions. J. Ethnopharmacol. 2000; 71: 45–53.
- 73 Hiraishi H, Terano A, Ota S et al. Protection of cultured rat gastric cells against oxidant induced damage by exogenous glutathione. Gastroenterology 1994; 106: 1199–207.
- 74 Sener-Muratoglu G, Paskaloglu K, Arbak S, Hurdag C, Ayanoglu-Dulger G. Protective effect of famotidine, omeprazole, and melatonin against acetylsalicyclic acid induced gastric damage in rats. Dig. Dis. Sci. 2001; 46: 318–30.
- 75 Hernandez-Munoz R, Montiel Ruiz C, Vazquez-Martinez O. Gastric mucosal cell proliferation in ethanol-induced chronic mucosal injury is related to oxidate stress and lipid peroxidation in rats. Lab. Invest. 2000; 80: 1161–9.
- 76 Bock KW, Lilienblum W, Fischer G, Schimer G, Bock Henning BS. The role of conjugation reactions in detoxication. Arch. Toxicol. 1987; 60: 22–9.
- 77 Wilce MCJ, Parker MW. Structure and function of glutathione-S-transferases. Biochim. Biophys. Acta 1994; 1205: 1–18.
- 78 Shaw S, Herbert V, Colman N, Jayatylleke E. Effect of ethanol-generated free radicals on gastric intrinsic factor and glutathione. Alcohol 1990; 7: 153–7.
- 79 Fridovich I. Biological effects of superoxide radical. Arch. Biochem. Biophys. 1986; 247: 1–11.
- 80 Das D, Banerjee RK. Effect of stress on the antioxidant enzymes and gastric ulceration. Mol. Cell Biochem. 1993; 125: 115–25.
- 81 Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam. Appl. Toxicol. 1995; 26: 293–300.
- 82 Singh R, Pathak DN. Lipid peroxidation and glutathione peroxidase, glutathione reductase, superoxide dismutase, catalase, and glucose-6-phosphate dehydrogenase activities in FeCl3-induced epileptogenic foci in the rat brain. Epilepsia 1990; 31: 15–26.
Citing Literature
